141 related articles for article (PubMed ID: 6615720)
1. Relationship between skin type and erythemal response to anthralin.
Maurice PD; Greaves MW
Br J Dermatol; 1983 Sep; 109(3):337-41. PubMed ID: 6615720
[TBL] [Abstract][Full Text] [Related]
2. Woronoff ring during anthralin therapy for psoriasis.
Gupta AK; Ellis CN; Goldfarb MT; Voorhees JJ
Arch Dermatol; 1986 Mar; 122(3):248. PubMed ID: 3954390
[No Abstract] [Full Text] [Related]
3. [Effect of various kinds of tar and tar concentrations on anthralin erythema].
Wemmer U; Schulze HJ; Mahrle G; Steigleder GK
Z Hautkr; 1986 Jun; 61(12):849-52. PubMed ID: 3751210
[TBL] [Abstract][Full Text] [Related]
4. [Suppression of cignolin-induced erythema by tar].
Schulze HJ
Z Hautkr; 1984 May; 59(10):659-62. PubMed ID: 6741205
[No Abstract] [Full Text] [Related]
5. [Reduction of erythema by the addition of bituminous coal tar in anthralin short-term therapy].
Heller G
Dermatol Monatsschr; 1985; 171(11):718-20. PubMed ID: 4085670
[No Abstract] [Full Text] [Related]
6. Anthralin inflammation versus UV-erythema in psoriatics.
Schauder S; Mahrle G
Br J Dermatol; 1983 Jul; 109 Suppl 25():117-9. PubMed ID: 6860579
[TBL] [Abstract][Full Text] [Related]
7. [Anthralin erythema: effect of concentration, contact time, oxidation products and corticosteroids. Clinical, reflection photometry and electron microscopy studies].
Puschmann M
Z Hautkr; 1983 Nov; 58(22):1646-7. PubMed ID: 6659639
[TBL] [Abstract][Full Text] [Related]
8. Short contact anthralin in the treatment of psoriasis: a study of different contact times.
MacDonald KJ; Marks J
Br J Dermatol; 1986 Feb; 114(2):235-9. PubMed ID: 3947539
[TBL] [Abstract][Full Text] [Related]
9. [Potential factors influencing dithranol erythema].
Richter G; Barth J
Dermatol Monatsschr; 1986; 172(5):272-5. PubMed ID: 3721033
[No Abstract] [Full Text] [Related]
10. [Effect of coal tar on cignolin erythema--1 hour treatment of psoriasis with high-dose cignolin with and without tar].
Schauder S; Mahrle G
Z Hautkr; 1985 Jun; 60(11):875-83. PubMed ID: 3160177
[TBL] [Abstract][Full Text] [Related]
11. [Suppression of dithranol erythema by the addition of tar in short-term therapy].
Wozel G; Barth J
Dermatol Monatsschr; 1985; 171(12):818-9. PubMed ID: 4092792
[No Abstract] [Full Text] [Related]
12. Effect of coal tar on cutaneous aryl hydrocarbon hydroxylase induction and anthralin irritancy.
Lawrence CM; Finnen MJ; Shuster S
Br J Dermatol; 1984 Jun; 110(6):671-5. PubMed ID: 6733038
[TBL] [Abstract][Full Text] [Related]
13. Irritation and staining by dithranol (anthralin) and related compounds. V. Short-contact and tape-stripping experiments with dithranol and butantrone.
Göransson AM; Kolari PJ; Mustakallio KK
Acta Derm Venereol; 1984; 64(2):134-9. PubMed ID: 6203301
[TBL] [Abstract][Full Text] [Related]
14. Irritant reactions to dithranol in normal subjects and psoriatic patients.
Kingston T; Marks R
Br J Dermatol; 1983 Mar; 108(3):307-13. PubMed ID: 6830696
[TBL] [Abstract][Full Text] [Related]
15. The irritancy of anthralin is inhibited by repeat applications of a subirritant concentration.
Parslew R; Friedmann PS
Br J Dermatol; 1999 Sep; 141(3):469-74. PubMed ID: 10583050
[TBL] [Abstract][Full Text] [Related]
16. Irritation and staining by dithranol (anthralin) and related compounds. III. Cumulative irritancy and staining during repeated chamber testing.
Brandt H; Mustakallio KK
Acta Derm Venereol; 1983; 63(3):237-40. PubMed ID: 6192640
[TBL] [Abstract][Full Text] [Related]
17. Irritancy of anthralin in patients with psoriasis and widespread vitiligo.
Roberts DL
Br J Dermatol; 1984 Feb; 110(2):247-8. PubMed ID: 6696841
[No Abstract] [Full Text] [Related]
18. Antipsoriatic therapy and skin cancer.
Briffa DV
Br J Dermatol; 1981 Aug; 105 Suppl 20():70. PubMed ID: 7284271
[No Abstract] [Full Text] [Related]
19. The inflammatory response to anthralin and its relation to aryl hydrocarbon hydroxylase.
Kersey P; Chapman P; Rogers S; Rawlins M; Shuster S
Br J Dermatol; 1981 Aug; 105 Suppl 20():64-7. PubMed ID: 6456755
[No Abstract] [Full Text] [Related]
20. A topical treatment program for psoriasis with low anthralin concentrations.
Brody I; Johansson A
J Cutan Pathol; 1977 Oct; 4(5):233-43. PubMed ID: 342554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
